[ 3 ] Bernatsky S, Ramsey-Goldman R, Clarke AE. Malignancy in systemic lupus erythematosus: what have we learned[J]. Best Pract Res Clin Rheumatol, 2009, 23(4): 539-547.
[ 5 ] Anderson LA, Pfeiffer RM, Landgren O, et al. Risks of myeloid malignancies in patients with autoimmune conditions[J]. Br J Cancer, 2009, 100(5): 822-828.
[6]
[ 6 ] Kittang AO, Hatfield K, Sand K, et al. The chemokine network in acute myelogenous leukemia: molecular mechanisms involved in leukemogenesis and therapeutic implications[J]. Curr Top Microbiol Immunol, 2010, 341: 149-172.
[7]
[ 7 ] Hase K, Tani K, Shimizu T, et al. Increased CCR4 expression in active systemic lupus erythematosus[J]. J Leukoc Biol, 2001, 70(5): 749-755.